US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Tracks Biotherapeutics Inc

43.11

+1.212.89%

Post-market: 43.440.3321+0.77%19:30 EDT

Volume:527.98K

Turnover:22.82M

Market Cap:1.54B

PE:-9.52

High:44.79

Open:42.98

Low:40.72

Close:41.90

52wk High:49.91

52wk Low:14.72

Shares:35.73M

Float Shares:34.75M

Volume Ratio:0.89

T/O Rate:1.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.5296

ROE:-48.91%

ROA:-28.97%

PB:9.13

PE(LYR):- -

Loading ...

Overview Company News Filings

Wells Fargo Reaffirms Their Buy Rating on First Tracks Biotherapeutics Inc (TRAX)

Analysts Offer Insights on NA Companies: Fervo Energy Company Class A (FRVO) and First Tracks Biotherapeutics Inc (TRAX)

First Tracks Price Target Maintained with a $30.00/share by HC Wainwright & Co.

Buy Rating on First Tracks (TRAX) Driven by Strengthening IL-15/CD122 Pathway Validation and Upcoming ANB033 Clinical Catalysts in Celiac Disease and Vitiligo

First Tracks Biotherapeutics Shares Edge Up on Sublease Deal

First Tracks Biotherapeutics subleases 45,057 sq ft San Diego space from AnaptysBio

First Tracks Biotherapeutics Inc. : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $30

THOMSON REUTERS

J.P. Morgan Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)

First Tracks net loss widens to $50.5 million in Q1 FY26

First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS

Two new option listings and one option delisting on May 11th

First Tracks Biotherapeutics files to sell 10.5M shares of common for holders

First Tracks Biotherapeutics Stock Slides After Investors Move to Sell 10 Million Shares

First Tracks Biotherapeutics Inc - Selling Stockholders May Sell up to 10.5 Shares of Common Stock - SEC Filing

THOMSON REUTERS

Piper Sandler Initiates Coverage on First Tracks Biotherapeutics With Overweight Rating, $54 Price Target

MT Newswires Live

First Tracks Initiated at Overweight by Piper Sandler

First Tracks Biotherapeutics initiated with an Overweight at Piper Sandler

Analysts Are Bullish on Top Healthcare Stocks: Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD), First Tracks Biotherapeutics Inc (TRAX)

HC Wainwright Initiates First Tracks Biotherapeutics at Buy

MT Newswires Live

First Tracks Initiated at Buy by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TRAX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TRAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","market":"US","secType":"STK","nameCN":"First Tracks Biotherapeutics Inc","latestPrice":43.11,"timestamp":1787342400000,"preClose":41.9,"halted":0,"volume":527979,"hourTrading":{"tag":"盘后","latestPrice":43.4421,"preClose":43.11,"latestTime":"19:30 EDT","volume":14359,"amount":619055.0136,"timestamp":1787355007160,"change":0.3321,"changeRate":0.007704,"amplitude":0.007704},"delay":0,"changeRate":0.028878281622911717,"floatShares":34748800,"shares":35730843,"eps":-4.529554,"marketStatus":"Not Yet Opened","change":1.21,"latestTime":"08-21 16:00:00 EDT","open":42.98,"high":44.785,"low":40.72,"amount":22822161.54429,"amplitude":0.097017,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.529554,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":41.9,"preHourTrading":{"tag":"盘前","latestPrice":41.9,"preClose":41.9,"latestTime":"08:57 EDT","volume":35,"amount":1462.80995,"timestamp":1787317069997,"change":0,"changeRate":0,"amplitude":0.063962},"postHourTrading":{"tag":"盘后","latestPrice":43.4421,"preClose":43.11,"latestTime":"19:30 EDT","volume":14359,"amount":619055.0136,"timestamp":1787355007160,"change":0.3321,"changeRate":0.007704,"amplitude":0.007704},"volumeRatio":0.8890807450568844,"impliedVol":0.8373,"impliedVolPercentile":0.6111},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","floatShares":34748800,"roa":"-28.97%","roe":"-48.91%","lyrEps":0,"volumeRatio":0.8890807450568844,"shares":35730843,"dividePrice":0,"high":44.785,"amplitude":0.097017,"preClose":41.9,"low":40.72,"week52Low":14.72,"pbRate":"9.13","week52High":49.9114,"institutionHeld":0,"latestPrice":43.11,"eps":-4.529554,"divideRate":0,"volume":527979,"delay":0,"ttmEps":-4.529554,"open":42.98,"prevYearClose":20,"prevWeekClose":44.04,"prevMonthClose":44.04,"prevQuarterClose":20.12,"fiveDayClose":44.04,"twentyDayClose":35.52,"sixtyDayClose":16.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"TRAX","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAX","date":"2026-08-21","current":-9.517493,"percent":0.148148,"low":-10.141689,"twenty":-8.651869,"median":-4.081492,"eighty":-3.504998,"high":-3.156022,"avg":-5.571542,"sd":2.501515,"marketCap":1497122321},"quantilePoints":[{"date":"2026-04-24","current":-3.975194,"twenty":-3.975194,"median":-3.975194,"eighty":-3.975194,"marketCap":660227979},{"date":"2026-05-01","current":-4.868566,"twenty":-4.868566,"median":-4.085034,"eighty":-3.799448,"marketCap":808605530},{"date":"2026-05-08","current":-3.728313,"twenty":-4.68236,"median":-4.236719,"eighty":-3.799448,"marketCap":619224346},{"date":"2026-05-15","current":-3.799448,"twenty":-4.433387,"median":-4.031683,"eighty":-3.799448,"marketCap":631038952},{"date":"2026-05-22","current":-3.452672,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"marketCap":584796305},{"date":"2026-05-29","current":-3.259026,"twenty":-4.249272,"median":-3.799448,"eighty":-3.475745,"marketCap":551997467},{"date":"2026-06-05","current":-3.749322,"twenty":-4.203244,"median":-3.738817,"eighty":-3.411676,"marketCap":635041334},{"date":"2026-06-12","current":-3.508294,"twenty":-4.109513,"median":-3.726221,"eighty":-3.329068,"marketCap":594217248},{"date":"2026-06-18","current":-3.743141,"twenty":-4.020386,"median":-3.683399,"eighty":-3.361617,"marketCap":633994562},{"date":"2026-06-26","current":-3.372329,"twenty":-3.945066,"median":-3.663829,"eighty":-3.37851,"marketCap":571188276},{"date":"2026-07-02","current":-3.829664,"twenty":-3.955109,"median":-3.663829,"eighty":-3.376449,"marketCap":648649362},{"date":"2026-07-10","current":-6.674616,"twenty":-4.112294,"median":-3.726221,"eighty":-3.397462,"marketCap":1130513144},{"date":"2026-07-17","current":-7.459502,"twenty":-4.261943,"median":-3.735727,"eighty":-3.424655,"marketCap":1263453116},{"date":"2026-07-24","current":-7.754091,"twenty":-4.794084,"median":-3.774042,"eighty":-3.434543,"marketCap":1313349220},{"date":"2026-07-31","current":-9.842999,"twenty":-6.999282,"median":-3.799448,"eighty":-3.441135,"marketCap":1667157964},{"date":"2026-08-07","current":-9.334163,"twenty":-7.464446,"median":-3.842801,"eighty":-3.45844,"marketCap":1580973783},{"date":"2026-08-14","current":-9.814035,"twenty":-7.742967,"median":-3.975194,"eighty":-3.486045,"marketCap":1573229017},{"date":"2026-08-21","current":-9.33927,"twenty":-8.651869,"median":-4.081492,"eighty":-3.504998,"marketCap":1497122321}],"updateTime":1787531132854},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2650189030","title":"Wells Fargo Reaffirms Their Buy Rating on First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650189030","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650189030?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:55","pubTimestamp":1783677344,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Derek Archila from Wells Fargo maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-reaffirms-their-buy-rating-on-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-reaffirms-their-buy-rating-on-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGF","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650824183","title":"Analysts Offer Insights on NA Companies: Fervo Energy Company Class A (FRVO) and First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650824183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650824183?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:11","pubTimestamp":1783671076,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Fervo Energy Company Class A (FRVO) and First Tracks Biother...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-fervo-energy-company-class-a-frvo-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-fervo-energy-company-class-a-frvo-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX","BK4133","BK4141","NA","BK4139","FRVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649991865","title":"First Tracks Price Target Maintained with a $30.00/share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2649991865","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649991865?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:48","pubTimestamp":1783518480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings(END) Dow Jones NewswiresJuly 08, 2026 09:48 ET","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649999736","title":"Buy Rating on First Tracks (TRAX) Driven by Strengthening IL-15/CD122 Pathway Validation and Upcoming ANB033 Clinical Catalysts in Celiac Disease and Vitiligo","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649999736?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:25","pubTimestamp":1783517125,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Emily Bodnar from H.C. Wainwright maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-first-tracks-trax-driven-by-strengthening-il-15-cd122-pathway-validation-and-upcoming-anb033-clinical-catalysts-in-celiac-disease-and-vitiligo-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-first-tracks-trax-driven-by-strengthening-il-15-cd122-pathway-validation-and-upcoming-anb033-clinical-catalysts-in-celiac-disease-and-vitiligo-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645008169","title":"First Tracks Biotherapeutics Shares Edge Up on Sublease Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2645008169","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645008169?lang=en_us&edition=fundamental","pubTime":"2026-06-23 05:27","pubTimestamp":1782163620,"startTime":"0","endTime":"0","summary":"Shares of First Tracks Biotherapeutics gained after the company disclosed it is subleasing office space from AnaptysBio.The stock rose 3.7% to $19 in after-hours trading on Monday. At market close, shares were up 6.6% in the past month.Under the agreement, AnaptysBio will sublease to First Tracks about 45,057 square feet of space in San Diego, Calif., First Tracks disclosed in a filing with the Securities and Exchange Commission.The sublease commenced on June 15 and has a term of 12 months, with the option to extend for a renewal period that would continue until April 4, 2028, or twelve months from the commencement of the renewal term, whichever is earlier.In April, First Tracks completed a spin-out from AnaptysBio.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645307748","title":"First Tracks Biotherapeutics subleases 45,057 sq ft San Diego space from AnaptysBio","url":"https://stock-news.laohu8.com/highlight/detail?id=2645307748","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645307748?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:06","pubTimestamp":1782158772,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics entered a 12-month sublease for about 45,057 rentable square feet at 10770 Wateridge Circle in San Diego.The sublease started June 15, 2026; it can be renewed to as late as April 4, 2028, subject to notice requirements.Monthly rent is set to match the master lease basic rent and additional rent; First Tracks also covers certain service charges it requests.The company can terminate at any time with at least three months’ prior written notice.The sublease ends automatically if AnaptysBio’s master lease rights terminate.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. First Tracks Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analy","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLj39vP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX","ANAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641485039","title":"First Tracks Biotherapeutics Inc. : Wells Fargo Initiates Coverage With Overweight Rating and Target Price $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2641485039","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641485039?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:44","pubTimestamp":1780915461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nAZN4T15QU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637322464","title":"J.P. Morgan Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637322464","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637322464?lang=en_us&edition=fundamental","pubTime":"2026-05-23 20:27","pubTimestamp":1779539237,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Anupam Rama maintained a Buy rating on First Tracks Biotherapeutics Inc yesterday and set a price target of $30.00. The company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635726571","title":"First Tracks net loss widens to $50.5 million in Q1 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2635726571","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635726571?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:36","pubTimestamp":1778790979,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics posted a wider net loss of USD 50.5 million for three months ended March 31, 2026, while research and development expense fell 18.1% to USD 34 million.General and administrative expense more than doubled to USD 18.9 million, while interest income dropped 43.9% to USD 2.3 million.Cash and cash equivalents totaled USD 286.5 million at March 31, down from USD 311.6 million at Dec. 31, 2025, with operating cash outflow narrowing to USD 32.6 million from USD 45 million a year earlier.Spin-off from AnaptysBio completed April 20, 2026, followed immediately by a private placement that raised about USD 80 million in gross proceeds at USD 13.81 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. First Tracks Bi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL3NrwF8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635723004","title":"First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635723004","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635723004?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:15","pubTimestamp":1778789701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA2WZCLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634233126","title":"Two new option listings and one option delisting on May 11th","url":"https://stock-news.laohu8.com/highlight/detail?id=2634233126","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634233126?lang=en_us&edition=fundamental","pubTime":"2026-05-11 23:26","pubTimestamp":1778513216,"startTime":"0","endTime":"0","summary":"New option listings for May 11th include Boost Run Inc. (BRUN) and First Tracks Biotherapeutics Inc (TRAX). Option delistings effective May 11th in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/two-new-option-listings-and-one-option-delisting-on-may-11th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/two-new-option-listings-and-one-option-delisting-on-may-11th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634984824","title":"First Tracks Biotherapeutics files to sell 10.5M shares of common for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2634984824","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634984824?lang=en_us&edition=fundamental","pubTime":"2026-05-09 06:52","pubTimestamp":1778280729,"startTime":"0","endTime":"0","summary":"16:38 EDT First Tracks Biotherapeutics (TRAX) files to sell 10.5M shares of common for holders Published first on TheFly – the ultimate source for ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/first-tracks-biotherapeutics-files-to-sell-10-5m-shares-of-common-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/first-tracks-biotherapeutics-files-to-sell-10-5m-shares-of-common-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634567460","title":"First Tracks Biotherapeutics Stock Slides After Investors Move to Sell 10 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2634567460","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634567460?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:47","pubTimestamp":1778276820,"startTime":"0","endTime":"0","summary":"Shares of First Tracks Biotherapeutics fell after it said existing stockholders would resell more than 10 million shares.The stock was down 4% at $18.67 after hours. It had closed at $17.92 on Thursday and then climbed almost 10% to $19.54 on Friday.The former subsidiary of AnaptysBio, which spun off in April, said shareholders would offload almost 10.5 million shares of common stock at prevailing market prices or in private deals.First Tracks won't receive any money from the sales. The selling shareholders previously participated in a private placement, in which they bought First Tracks shares at $13.81 apiece.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ISBC","BK4211","TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634946297","title":"First Tracks Biotherapeutics Inc - Selling Stockholders May Sell up to 10.5 Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2634946297","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634946297?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:38","pubTimestamp":1778272718,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nFWN41L1W9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632953840","title":"Piper Sandler Initiates Coverage on First Tracks Biotherapeutics With Overweight Rating, $54 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2632953840","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632953840?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:18","pubTimestamp":1777897136,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics, Inc. (TRAX) has an average rating of Buy and mean price target of $39.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic rese","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632893486","title":"First Tracks Initiated at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2632893486","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632893486?lang=en_us&edition=fundamental","pubTime":"2026-05-04 17:48","pubTimestamp":1777888080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 04, 2026 05:48 ET (09:48 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632139939","title":"First Tracks Biotherapeutics initiated with an Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2632139939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632139939?lang=en_us&edition=fundamental","pubTime":"2026-05-04 16:40","pubTimestamp":1777884030,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi initiated coverage of First Tracks Biotherapeutics (TRAX) with an Overweight rating and $54 price target The c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/first-tracks-biotherapeutics-initiated-with-an-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/first-tracks-biotherapeutics-initiated-with-an-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632162047","title":"Analysts Are Bullish on Top Healthcare Stocks: Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD), First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632162047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632162047?lang=en_us&edition=fundamental","pubTime":"2026-05-02 17:03","pubTimestamp":1777712583,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Resmed Inc CHESS Depositary Interests on a ratio of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-aurmd-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-resmed-inc-chess-depositary-interests-on-a-ratio-of-10-cdis-per-ord-sh-aurmd-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4112","BK4567","LU0128526141.USD","XBI","LU2008162690.USD","BLSX","BK4137","TRAX","LABU","BK4548","BK4139","BK4581","BLSG","LU2177674079.SGD","RMD.AU","LU0170899867.USD","BK4585","BK4588","BK4504","BK4082","IE00B5TLWC47.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630866306","title":"HC Wainwright Initiates First Tracks Biotherapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2630866306","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630866306?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:25","pubTimestamp":1777375503,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics (TRAX) has an average rating of buy and mean price target of $37, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630430638","title":"First Tracks Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2630430638","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630430638?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:25","pubTimestamp":1777375500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 28, 2026 07:25 ET (11:25 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}]}}